Artia Global Partners LP Quant / Systematic

CIK: 0001937964 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $366,884 (100.0% shares, 0.0% debt)

Holdings (45)

NVO NOVO-NORDISK A S 24.1%
Value ($000) $88,319 Shares 741,743 Est. Cost $113.72 Unrealized
LLY ELI LILLY & CO 22.4%
Value ($000) $82,032 Shares 92,593 Est. Cost $527.62 Unrealized +68.7%
VKTX VIKING THERAPEUTICS INC 9.2%
Value ($000) $33,737 Shares 532,879 Est. Cost $28.32 Unrealized +107.1%
INTRA-CELLULAR THERAPIES INC 4.3%
Value ($000) $15,843 Shares 216,519 Est. Cost $66.05 Unrealized
AZN ASTRAZENECA PLC 4.1%
Value ($000) $14,861 Shares 190,752 Est. Cost $69.76 Unrealized
SLNO SOLENO THERAPEUTICS INC 3.8%
Value ($000) $13,856 Shares 274,424 Est. Cost $46.41 Unrealized +3.2%
LLY ELI LILLY & CO 3.6%
Value ($000) $13,289 Shares 15,000 Est. Cost $527.62 Unrealized +68.7%
ALNY ALNYLAM PHARMACEUTICALS INC 2.6%
Value ($000) $9,626 Shares 35,000 Est. Cost $157.87 Unrealized +64.9%
VRTX VERTEX PHARMACEUTICALS INC 2.4%
Value ($000) $8,790 Shares 18,900 Est. Cost $422.74 Unrealized +13.6%
PCVX VAXCYTE INC 2.4%
Value ($000) $8,714 Shares 76,255 Est. Cost $56.71 Unrealized +58.9%
ARGX ARGENX SE 2.2%
Value ($000) $8,206 Shares 15,138 Est. Cost $387.47 Unrealized
AXSM AXSOME THERAPEUTICS INC 2.2%
Value ($000) $7,895 Shares 87,848 Est. Cost $73.77 Unrealized +18.3%
PTGX PROTAGONIST THERAPEUTICS INC 1.5%
Value ($000) $5,600 Shares 124,440 Est. Cost $25.24 Unrealized +60.1%
NBIX NEUROCRINE BIOSCIENCES INC 1.4%
Value ($000) $5,185 Shares 45,000 Est. Cost $117.13 Unrealized +17.0%
RVMD REVOLUTION MEDICINES INC 1.2%
Value ($000) $4,348 Shares 95,885 Est. Cost $43.54 Unrealized 0.0%
DYN DYNE THERAPEUTICS INC 1.2%
Value ($000) $4,292 Shares 119,488 Est. Cost $22.62 Unrealized +76.0%
VERONA PHARMA PLC 1.2%
Value ($000) $4,275 Shares 148,590 Est. Cost $20.94 Unrealized
MERUS N V 1.1%
Value ($000) $4,005 Shares 80,171 Est. Cost $46.87 Unrealized
INSM INSMED INC 1.1%
Value ($000) $3,865 Shares 52,939 Est. Cost $26.68 Unrealized +176.6%
CLDX CELLDEX THERAPEUTICS INC NEW 0.7%
Value ($000) $2,559 Shares 75,300 Est. Cost $37.73 Unrealized +1.0%
CRNX CRINETICS PHARMACEUTICALS IN 0.6%
Value ($000) $2,339 Shares 45,765 Est. Cost $39.13 Unrealized +31.8%
IDYA IDEAYA BIOSCIENCES INC 0.5%
Value ($000) $1,996 Shares 62,992 Est. Cost $42.20 Unrealized -10.1%
MREO MEREO BIOPHARMA GROUP PLC 0.5%
Value ($000) $1,732 Shares 421,359 Est. Cost $3.30 Unrealized
SPRINGWORKS THERAPEUTICS INC 0.5%
Value ($000) $1,728 Shares 53,930 Est. Cost $49.22 Unrealized
NUVL NUVALENT INC 0.4%
Value ($000) $1,579 Shares 15,437 Est. Cost $82.95 Unrealized 0.0%
XENE XENON PHARMACEUTICALS INC 0.4%
Value ($000) $1,575 Shares 40,000 Est. Cost $46.00 Unrealized -12.3%
CNTA CENTESSA PHARMACEUTICALS PLC 0.4%
Value ($000) $1,285 Shares 80,380 Est. Cost $15.99 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 0.3%
Value ($000) $1,249 Shares 156,300 Est. Cost $11.36 Unrealized -22.7%
CRL CHARLES RIV LABS INTL INC 0.3%
Value ($000) $1,242 Shares 6,305 Est. Cost $226.63 Unrealized -8.3%
IONS IONIS PHARMACEUTICALS INC 0.3%
Value ($000) $1,221 Shares 30,479 Est. Cost $41.01 Unrealized +13.4%
KROS KEROS THERAPEUTICS INC 0.3%
Value ($000) $1,161 Shares 20,000 Est. Cost $53.73 Unrealized -8.1%
KURA KURA ONCOLOGY INC 0.3%
Value ($000) $1,117 Shares 57,178 Est. Cost $19.79 Unrealized +2.4%
ASND ASCENDIS PHARMA A/S 0.3%
Value ($000) $1,111 Shares 7,440 Est. Cost $151.17 Unrealized
ANNX ANNEXON INC 0.3%
Value ($000) $1,020 Shares 172,226 Est. Cost $5.30 Unrealized +11.9%
CRBP CORBUS PHARMACEUTICALS HLDGS 0.3%
Value ($000) $978 Shares 47,400 Est. Cost $47.33 Unrealized +8.1%
SLN SILENCE THERAPEUTICS PLC 0.3%
Value ($000) $954 Shares 52,476 Est. Cost $21.60 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.3%
Value ($000) $929 Shares 48,263 Est. Cost $20.93 Unrealized -1.3%
NAMS NEWAMSTERDAM PHARMA COMPANY 0.2%
Value ($000) $901 Shares 54,285 Est. Cost $20.30 Unrealized -14.8%
ALEC ALECTOR INC 0.2%
Value ($000) $901 Shares 193,317 Est. Cost $5.36 Unrealized 0.0%
IRON DISC MEDICINE INC 0.2%
Value ($000) $660 Shares 13,440 Est. Cost $64.84 Unrealized -27.6%
LRMR LARIMAR THERAPEUTICS INC 0.2%
Value ($000) $593 Shares 90,490 Est. Cost $7.74 Unrealized +3.8%
ACELYRIN INC 0.1%
Value ($000) $459 Shares 93,114 Est. Cost $4.93 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 0.1%
Value ($000) $330 Shares 1,557 Est. Cost $235.62 Unrealized +8.6%
SMMT SUMMIT THERAPEUTICS INC 0.1%
Value ($000) $318 Shares 14,512 Est. Cost $13.98 Unrealized 0.0%
QTTB Q32 BIO INC 0.1%
Value ($000) $210 Shares 4,705 Est. Cost $36.74 Unrealized 0.0%